Search results
Novavax Starts A New Chapter, Turning The Page On Financial Uncertainty
RTT News· 3 hours agoJust when the Covid-vaccine maker Novavax Inc.'s (NVAX) future as a going concern seemed uncertain, a remarkable turnaround has unfolded, thanks to the ...
Some Breather For Novavax's COVID-19 Vaccine, Inks Multibillion-Dollar Deal With Sanofi And Erases...
Benzinga via Yahoo Finance· 3 days agoThe terms of the agreement include: A co-exclusive license to co-commercialize Novavax’s current...
Novavax Reports First Quarter 2024 Financial Results and Operational Highlights
FOX 4 Kansas City· 3 days ago...combination product near-term milestones, plus ongoing tiered royalties on product salesUp to $200 million in milestones plus royalties for each new vaccine developed utilizing Novavax's Matrix-MTM adjuvantAnnounces addition of standalone influenza vaccine to Phase 3 COVID-19-Influenza...
Novavax and Sanofi Announce Co-exclusive Licensing Agreement to Co-commercialize COVID-19 Vaccine...
CBS 47 Fresno· 3 days ago...Agreements and in India, Japan and South Korea where Novavax has existing partnership agreements); a sole license to Novavax's adjuvanted COVID-19 vaccine for use in combination with Sanofi's flu vaccines while Novavax retains the right to and is developing its own COVID-19-Influenza Combination ...
Novavax Inc (NVAX) Q1 2024 Earnings: Navigating Challenges with Strategic Partnerships and Cost ...
GuruFocus.com via Yahoo Finance· 3 days agoThe company's strategic financial management is evident in its updated full-year 2024 guidance, projecting combined revenue and Sanofi agreement payments to reach between ...
Novavax Inc (NVAX) Q1 2024 Earnings: Navigating Challenges with
Guru Focus· 3 days agoThe company, a prominent player in the biotechnology sector focusing on the development of vaccines, reported a net loss of $147.55 million with a loss per share of $1.05.
AstraZeneca’s COVID vaccine withdrawn – right to the end it was the victim of misinformation -...
EconoTimes· 4 days agoThe Oxford-AstraZeneca vaccine was a critical part of the COVID-19 pandemic response. This EU...
Morning Brew: Novavax Soars on Sanofi Deal, Roblox Rebounds on U
Guru Focus· 3 days agoStock market futures indicate a positive opening for the final trading day of the week. Here's a...
Stocks Pause On Dismal Consumer Confidence; Yields, Dollar Rise As Inflation Expectations Kick...
Benzinga via Yahoo Finance· 3 days agoEditor’s note: This story has been updated to correct an error in the price action of Charter...
